Parnell Pharmaceuticals Holdings PE Ratio 2014-2018 | PARNF
Current and historical p/e ratio for Parnell Pharmaceuticals Holdings (PARNF) from 2014 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Parnell Pharmaceuticals Holdings PE ratio as of June 02, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Parnell Pharmaceuticals Holdings PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-04-22 |
0.08 |
|
0.00 |
| 2018-06-30 |
0.18 |
$-0.12 |
0.00 |
| 2018-03-31 |
0.30 |
$-0.39 |
0.00 |
| 2017-12-31 |
0.60 |
$-0.84 |
0.00 |
| 2016-12-31 |
0.69 |
$-0.97 |
0.00 |
| 2016-09-30 |
1.42 |
$-1.04 |
0.00 |
| 2015-12-31 |
3.88 |
$-0.77 |
0.00 |
| 2015-09-30 |
3.44 |
$-0.32 |
0.00 |
| 2015-06-30 |
4.95 |
$-0.29 |
0.00 |
| 2015-03-31 |
4.91 |
$-0.10 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Parnell Pharmaceuticals Holdings Ltd. is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing animal health solutions. It manufactures and markets cattle reproduction, cattle mastitis, anesthetics, laminitis treatment, and orthopedic treatment products. The Company operates in four segments: Companion Animal, Production Animal-Unites States, and Production Animal-rest of the world and Manufacturing Operations. ZYDAX (R), GLYDE (R) and TERGIVE (R) are Parnell's premium osteoarthritis product suite. Parnell Pharmaceuticals Holdings Ltd. is headquartered in Alexandria, Australia.
|
